3ARH Report issue

For profit Phase 4
Founded: Ljubljana Slovenia (2005)

Organization Overview

First Clinical Trial
2019
NCT04246619
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

3ARH

Active Ingredients

Drugs in Phase 4 Trials (2)

duloxetine (Cymbalta) (1 trial)

pregabalin (lyrica) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetic Neuropathies (Phase 4)

Pain (Phase 4)

Peripheral Nervous System Diseases (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2